Newbury Park, CA, United States of America

Jonathan Daniel Oliner

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 2.2

ph-index = 9

Forward Citations = 251(Granted Patents)


Location History:

  • Newbury Park, CA (US) (2006 - 2015)
  • Garrett Park, MD (US) (2019 - 2022)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan Daniel Oliner

Introduction

Jonathan Daniel Oliner, an accomplished inventor based in Newbury Park, California, stands out in the field of medical research with a portfolio of 16 patents. His innovative work primarily focuses on improving cancer treatment methodologies, showcasing his commitment to advancing healthcare through scientific discovery.

Latest Patents

Two of Oliner's most recent patents reflect his relentless pursuit of breakthroughs in pharmaceutical applications. The first patent, titled "Ex vivo systems and methods for determining the effect of a drug or other agent on a tissue," outlines a novel approach to predicting how tissues respond to various drugs. This method involves cutting tissues into fragments, applying the drug based on estimated tumor content, and subsequently measuring the tissue response. The second patent focuses on "Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers." This invention details therapeutic strategies utilizing MDM2 inhibitors alongside other active agents, aimed at enhancing cancer treatment efficacy through innovative pharmaceutical compositions.

Career Highlights

Oliner has had a profound impact while working with eminent organizations, including Amgen Inc. and Medarex Inc. His experiences in these companies have significantly contributed to the development of groundbreaking therapeutic approaches, strengthening his role as a key player in the field of oncology and drug development.

Collaborations

Throughout his career, Oliner has partnered with several esteemed colleagues, including Hosung Min and Thomas Charles Boone. These collaborations have fostered an environment of innovation, enabling the exchange of ideas and the furtherance of research that has the potential to transform cancer treatment.

Conclusion

Jonathan Daniel Oliner's contributions to the medical field through his inventive patents underscore his role as a leading figure in cancer research. His innovative methods and collaborative spirit continue to inspire advancements in pharmaceutical sciences, potentially leading to more effective treatments for patients battling cancer. As the exploration of new therapies persists, Oliner's work remains crucial in the drive toward enhanced healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…